IGHE and anaphylaxis: The anaphylaxis event was of grade 2 severity, with a serious criterion of “medically important.” This day 0 unexpected event was associated with features of an immediate type 1 (IgE-mediated) hypersensitivity event and was considered related to the study drug by the investigator.